on
7th European Biosimilars Congress
May 15-16, 2017 Munich, Germany
Home ABOUT OPEN ACCESS CONFERENCES JOURNALS FAQs BLOG CONTACT
Biosimilars-euro 2017
Home
Gallery
Biosimilars-euro 2017 Report

Conference Series hosted the 7th  European Biosimilars Congress at Novotel München City Arnulfpark Munich, Germany during May 15-16, 2017.The conference was designed around the theme of “The developmental strategies and uptake of biosimilars through a decade in Europe” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.

Euro Biosimilars 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics and Biosimilars. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in developing a biosimilar.

Conference Series would like to convey a warm gratitude to all the Honorable guests, Keynote Speakers, Delegates, Media Partners and Exhibitors for their participation in Euro Biosimilars 2017.

Christoph Volpers, Michalski & Hüttermann, Germany

Arthur G Cook, ZS Associates, USA

Tim Demuth, Sandoz Pharmaceuticals GmbH, Germany

Rosa Helena Bustos, University of La Sabana, Colombia

Ulrike Konrad, Protagen Protein Services , Germany

Stanley Seung Suh Hong, Celltrion Healthcare Co. Ltd., South Korea

Ulrich Storz, Michalski Hüttermann & Partner, Germany

We on behalf of the conference specially thank the exhibitors for their participation in the congress and  also the media partners for their wonderful marketing of the event. Conference Series also took the privilege of felicitating Euro Biosimilars 2017 Organizing Committee, Keynote Speakers and Chair whose support made conference a great success.

With the enormous feedback from the participants and supporters of Euro Biosimilars 2017, we are glad to announce 11th European Biosimilars Congress during June 04-06, 2018 at London, UK



Expert Presentations
Kamali Chance

Quintiles, Inc,

USA
Ruediger Jankowsky

Cinfa Biotech GmBH

Germany
Andreu Soldevila Fabrega

Lean BioPro

Spain
Laszlo Endrenyi

University of Toronto, Canada

Canada
Candida Fratazzi

BBCR Consulting

USA
Conference Secretariat: Biosimilars-euro 2017, Conference Series Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
Tel: +1-650-268-9744, Fax: +1-650-618-1414
Toll free: 1-800-216-6499(USA & Canada),
1-800-651-097(Australia), 0805-080048(Europe)
Operated by: Editors - Journal of Bioanalysis & Biomedicine, Journal of Bioequivalence & Bioavailability and Journal of Pharmaceutical Sciences & Emerging Drugs
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2008-2012 Conference Series - All rights reserved